REVIEW PAPER
Use of scintigraphy in rheumatology
Online publication date: 2009-12-29
Reumatologia 2012;50(6):290-299
KEYWORDS
ABSTRACT
Scintigraphy is a simple, non-invasive imaging technique using various radionuclides for the diagnosis of many disorders. In this article we present the use of scintigraphy in detection of some rheumatoid diseases based on the clinical experience of many medical centres, with evaluation of its diagnostic value in particular diseases.
REFERENCES (59)
1.
Macfarlane DG, Buckland-Wright JC, Emery P, et al. Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands. Ann Rheum Dis 1991; 50: 623-626.
2.
Vizda J, Krizova H, Urbanova E. Atlas of bone scintigraphy. Lacomed, Praga 2006: 12.
3.
Rydgren L, Wollmer P, Hultquist R, Gustafson T. 111Indium-labelled leukocytes for measurement of inflammatory activity in arthritis. Scand J Rheumatol 1991; 20: 319-325.
4.
de Bois MH, Welling M, Yerwey CL, et al. 99mTc-HIG accumulates in the synovial tissue of rats with adjuvant arthritis by binding to extracellular matrix proteins. Nucl Med Commun 1996; 17: 54-59.
5.
de Bois MH, Tak PP, Arndt JW, et al. Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to histological examination. Clin Exp Rheumatol 1995; 13: 155-159.
6.
Love C, Tomas MB, Marwin SE, et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21: 1229-1238.
7.
Sonmezoglu K, Sonmezoglu M, Halac M, et al. Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nuci Med 2001; 42: 567-574.
8.
Appelboom T, Emery P, Tant L, et al. Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford) 2003; 42: 1179-1182.
10.
Larikka MJ, Ahonen AK, Niemelä O, et al. Comparison of 99mTc ciprofloxacin, 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun 2002; 23: 655-661.
11.
Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991; 179: 645-648.
12.
Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39: 346-350.
13.
Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009; 39: 52-65.
14.
Olejárová M, Kupka K, Pavelka K, et al. Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis. Results of a two-year study. Joint Bone Spine 2000; 67: 107-112.
15.
Duer A, O/stergaard M, Ho/rslev-Petersen K, Vallo/ J. Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis. Ann Rheum Dis2008; 67: 48-51.
16.
de Bois MH, Arndt JW, Speyer I, et al. Technetium-99m labelled human immunoglobulin scintigraphy predicts rheumatoid arthritis in patients with arthralgia. Scand J Rheumatol 1996; 25: 155-158.
17.
Shi XH, Zhang FC, Chen LB, Ouyang M. The value of 99mTc methylene diphosphonate bone scintigraphy in diagnosing relapsing polychondritis. Chin Med J (Engl) 2006; 119: 1129-1132.
18.
de Bois MH, Arndt JW, van der Velde EA, et al. Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to late phase scintigraphy with 99mTc-labelled diphosphonate. Br J Rheumatol 1994; 33: 67-73.
19.
Martins FP, Gutfilen B, de Souza SA, et al. Monitoring rheumatoid arthritis synovitis with 99mTc-anti-CD3. Br J Radiol 2008; 81: 25-29.
20.
Kinne RW, Becker W, Schwab J, et al. Imaging rheumatoid arthritis joints with technetium-99m labelled specific anti-CD4- and non-specific monoclonal antibodies. Eur J Nucl Med 1994; 21: 176-180.
21.
Barrera P, van der Laken CJ, Boerman OC, et al. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 870-874.
22.
de Bois MH, Pauwels EK, Breedveld FC. New agents for scintigraphy in rheumatoid arthritis. Eur J Nucl Med 1995; 22: 1339-1346.
23.
Roivainen A, Parkkola R, Yli-Kerttula T, et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 2003; 48: 3077-3084.
24.
Post AM, Katsikis PD, Tait JF, et al. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med 2002; 43: 1359-1365.
25.
van der Laken CJ, Yoskuyl AE, Roos JC, et al. Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis. Ann Rheum Dis 2007; 66: 253-256.
26.
Nolla-Solé JM, Mateo-Soria L, Rozadilla-Sacanell A, et al. Role of technetium-99m diphosphonate and gallium-67 citrate bone scanning in the early diagnosis of infectious spondylodiscitis. A comparative study. Ann Rheum Dis 1992; 51: 665-667.
27.
Elkayam O, Paran D, Even-Sapir E, et al. Abdominal scintigraphy using technetium Tc 99m hexylmethylpropylene amine oxime-labeled leukocytes in patients with seronegative spondyloarthropathies. Semin Arthritis Rheum 2002; 31: 406-412.
28.
Beier JM, Andersen L, Hansen TM, Frederiksen PB. Gastrointestinal accumulation of indium-111 labelled granulocytes in reactive arthritis. Br J Rheumatol 1992; 31: 543-545.
29.
Rau R, Wasserberg S, Backhaus M, et al. Imaging methods in rheumatology: imaging in psoriasis arthritis (PsA). Z Rheumatol 2006; 65: 159-167.
30.
Coleman RE, Mashiter G, Whitaker KB, et al. Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 1988; 29: 1354-1359.
31.
Macro M, Bouvard G, Le Gangneux E, et al. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study. Rev Rhum Engl 1995; 62: 99-104.
32.
Dreher R, Buttgereit F, Demary W, et al. Insufficiency fractures in rheumatology. Case report and overview. Z Rheumatol 2006; 65: 417-423.
33.
Palestro CJ, Love C, Tronco GG, et al. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics 2006; 26: 859-870.
34.
Maillefert JF, Toubeau M, Piroth C, et al. Bone scintigraphy equipped with a pinhole collimator for diagnosis of a vascular necrosis of the femoral head. Clin Rheumatol 1997; 16: 372-377.
36.
Jónsson H, Elíasson GJ, Pétursson E. Scintigraphic hand osteoarthritis (OA)--prevalence, joint distribution, and association with OA at other sites. J Rheumatol 1999; 26: 1550-1556.
37.
McCarthy C, Cushnaghan J, Dieppe P. The predictive role of scintigraphy in radiographic osteoarthritis of the hand. Osteoarthritis Cartilage 1994; 2: 25-28.
38.
Clunie G, Bomanji J, Ell PJ. Technetium-99m-MDP patterns in patients with painful shoulder lesions. J Nucl Med 1997; 38: 1491-1495.
39.
Rotés-Sala D, Monfort J, Solano A, et al. The clover and heart signs in vertebral scintigraphic images are highly specific of Paget’s disease of bone. Bone 2004; 34: 605-608.
40.
Ryan PJ, Fogelman I. Bone scintigraphy in metabolic bone disease. Semin Nucl Med 1997; 27: 291-305.
41.
Casari S, Rossi V, Varenna M, et al. A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan. Clin Exp Rheumatol 2003; 21: 493-496.
42.
Dowman JK, Khattak FH. Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan. Ann Rheum Dis 2006; 65: 1664.
43.
Reitblat T, Ben-Horin CL, Reitblat A. Increased 67gallium uptake among połymyalgia rheumatica patients. Is it additional evidence of its vasculitic nature? Rheumatol Int 2006; 26: 1010-1013.
44.
Naschitz JE, Slobodin G, Yeshumn D, et al. A polymyalgia rheumatica-like syndrome as presentation of metastatic cancer. J Clin Rheumatol 1996; 2: 305-308.
45.
Häntzschel H, Bird HA, Seidel W, et al. Polymyalgia rheumatica and rheumatoid arthritis of the elderly: a clinical, laboratory, and scintigraphic comparison. Ann Rheum Dis 1991; 50: 619-622.
46.
Henriksen AM, Nossent HC. Quantitative salivary gland scintigraphy can distinguish patients with primary Sjögren’s syndrome during the evaluation of sicca symptoms. Clin Rheumatol 2007; 26: 1837-1841.
47.
Nishiyama S, Miyawaki S, Yoshinaga Y. A study to standardize quantitative evaluation of parotid gland scintigraphy in patients with Sjögren’s syndrome. J Rheumatol 2006; 33: 2470-2474.
48.
Markusse HM, Pillay M, Cox PH. A quantitative index derived from 99mTc-pertechnetate scintigraphy to assist in the diagnosis of primary Sjögren’s syndrome. Nuklearmedizin 1992; 31: 3-6.
49.
Markusse HM, Pillay M, Breedveld FC. The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjögren’s syndrome. Br J Rheumatol 1993; 32: 231-235.
50.
Hazenberg BP, van Gameren II, Bijzet J, et al. Diagnostic and therapeutic approach of systemie amyloidosis. Neth J Med 2004; 62: 121-128.
51.
Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, et al. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis. J Nucl Med 2007; 48: 865-872.
52.
Hazenberg BP, van Rijswijk MH, Piers DA, et al. Diagnostic performance of 1231-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006; 119: 15-24.
53.
Caleiro MT, Lage LV, Navarro-Rodriguez T, et al. Radionuclide imaging for the assessment of esophageal motility disorders in mixed connective tissue disease patients: relation to pulmonary impairment. Dis Esophagus 2006; 19: 394-400.
54.
Kaye SA, Siraj QH, Agnew J, et al. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method. J Rheumatol 1996; 23: 297-301.
55.
Gaál J, Varga J, Szabados L, et al. High prevalence of oesophageal involvement in patients with undifferentiated connective tissue disease using radionuclide oesophageal transit scintigraphy. Nucl Med Commun 2005; 26: 1113-1117.
56.
Scott DL, Kingsley GH. Use of imaging to assess patients with muscle disease. Curr Opin Rheumatol 2004; 16: 678-683.
57.
Walker UA, Garve K, Brink I, et al. 99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease. Clin Rheumatol 2007; 26: 1119-1122.
58.
Sahin M, Yildiz M, Tunc SE, et al. The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet’s disease. Ann Nucl Med 2006; 20: 649-653.
59.
Eklund A, Jacobsson H, Larsson SA, Sköld CM. Detection of extrathoracic manifestations in sarcoidosis with somatostatin analogue scintigraphy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 146-151.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
